Oklahoma lawmaker urges Oklahoma Corporation Commission to protect PSO ratepayers

An Oklahoma lawmaker is urging the Oklahoma Corporation Commission to protect Public Service Company of Oklahoma (PSO) ...

OK Corporation Commission continues review of PSO’s proposed $600 million rate increase

OK Corporation Commission continues review of PSO’s proposed $600 million rate increase ...

The state that shuts off poor families’ power more often than anywhere else

TULSA - The lights went out when Tammy Dikes was in the shower. All of a sudden, her windowless bathroom went black. It was ...

Issue Of Police Safety Order On Protection Order Applicant Not Justified

The Independent Police Conduct Authority has found that Police were unjustified in issuing a Police Safety Order (PSO) ...

Police Acknowledge IPCA Findings – Counties Manukau

Police acknowledge the findings of the Independent Police Conduct Authority (IPCA) into the handling of a Police Safety Order (PSO) issued in south Auckland. On 25 June 2025, Police responded to a ...

In Oklahoma, poor families often have to live in the dark

TULSA - The lights went out when Tammy Dikes was in the shower. All of a sudden, her windowless bathroom went black. It was ...
Interfax-Ukraine

Ukraine needs to rethink Ukrzaliznytsia's business model and index freight rates – EBRD

Ukrzaliznytsia’s business model, which relied on cross-subsidizing passenger transport with freight revenue without state ...
Independent.ie

€11m park‑and‑ride ‘substantially complete’ but there is no money left for buses to serve it

An €11m park‑and‑ride facility has been “sitting idle for months” but there is no funding to run the buses that would serve ...

Govt suspends licence of Kantanka Security Service

The government, through the Ministry of the Interior, has suspended the licence of Kantanka Security Services Limited ...

Oruka Therapeutics' Head of Finance Sold Over 10,000 Company Shares. What Does That Mean for Investors?

Detailed price information for Oruka Therapeutics Inc (ORKA-Q) from The Globe and Mail including charting and trades.
Le Lézard

Takeda's Zasocitinib Achieved Significantly Greater Complete Skin Clearance Than Deucravacitinib in Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations

Takeda Canada Inc. ("Takeda") is pleased to announce positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279), an investigational, ...